Product
ICI treatment
1 clinical trial
1 indication
Indication
Lung CancerClinical trial
Integrative Analysis of the Tumor Microenvironment and Optimization of the Immunotherapy Duration in Non-small Cell Lung Cancer Patients (OPTIMUNE-LUNG Study)Status: Active (not recruiting), Estimated PCD: 2025-08-01